The SPAC Market in 2025–2026 — A Recovery Grounded in Structural Reform

From Trough to Recovery — The Data in Context

The SPAC market's cycle from peak to trough to recovery is one of the most dramatic in recent U.S. capital markets history. In 2021, 613 SPAC IPOs raised $144.53 billion — an almost incomprehensible concentration of blank-check vehicle launches in a single calendar year. The regulatory, structural, and market dynamics that drove that peak proved unsustainable. By 2022, SPAC IPO volume had fallen to 86 transactions. By 2023, it had reached a trough of 31, with gross proceeds of approximately $3.4 billion. The recovery began in 2024, when 57 SPACs raised approximately $9.6 billion at a median deal size of $168 million — already more than double 2023's median — and accelerated sharply in 2025.

The 144 SPAC IPOs completed in 2025, raising between $26.86 billion and $30.4 billion depending on the measurement methodology, represent a genuine and substantial volume recovery. On raw count, 2025 produced nearly five times 2023's trough. On gross proceeds, it approached or exceeded the totals of 2019 ($13.6 billion) and 2020 ($83.4 billion, though that figure includes the early stages of the peak-era bubble). The structure has demonstrably returned to relevance as a capital markets tool.

What must be equally clear, however, is that the 2025 recovery is not a return to 2021 conditions. The 2021 cohort was characterized by first-time sponsors, aggressive valuations, minimal due diligence discipline, and structural features — particularly large warrant packages — that embedded dilution and post-close underperformance into most transactions. The 2025 recovery is built on a substantially different foundation: experienced repeat sponsors, tighter structures, and a regulatory framework that imposes IPO-equivalent disclosure and liability standards on every de-SPAC transaction.

Who Is Winning — The Serial Sponsor Dominance

The defining structural characteristic of the 2025 SPAC recovery is the concentration of new issuance activity among serial and repeat sponsors. According to data from Gallagher and Ellenoff Grossman & Schole's 2025 SPAC market review, 78 to 80% of new SPAC IPOs launched in early 2025 were sponsored by teams that had previously completed at least one SPAC IPO. This marks a dramatic shift from the 2020–2021 era, when first-time sponsors flooded the market, many with no prior public company experience or transaction track record.

The dominance of repeat sponsors matters for several reasons. These sponsors understand the post-2024 SEC disclosure requirements and have updated their standard documents accordingly. They have established relationships with institutional PIPE investors who have provided capital on prior transactions. They have experience navigating SEC comment review cycles, managing shareholder redemption dynamics, and structuring trust accounts to survive extension periods with minimal capital erosion. Most importantly, they have a track record that target companies and their advisors can evaluate — something the first-time sponsors of 2020–2021 could not provide.

For companies evaluating a SPAC merger, this market dynamic has a practical implication: the pool of credible, well-resourced potential acquirers is smaller and more identifiable than it was during the peak. Rather than receiving inbound from dozens of unknown sponsors, a company preparing for a SPAC transaction in 2025–2026 can conduct a focused evaluation of the active repeat-sponsor cohort and select a partner based on demonstrated track record, sector alignment, and institutional relationships. This is a better environment for target companies than the undifferentiated frenzy of 2021.

Redemption Rate Trends — What the Quarterly Data Shows

Redemption rates — the percentage of public SPAC shares redeemed by shareholders rather than held into a business combination — are one of the most direct available measures of deal quality and investor confidence. When a shareholder redeems, they are choosing to take $10.00 back rather than remain invested in the combined company. Rates close to 100% indicate that virtually all public shareholders prefer cash to equity — the most negative possible signal about how the market views the announced deal. Rates close to zero indicate strong conviction across the shareholder base.

The 2025 quarterly data shows a clear improving trend as the year progressed. Q1 2025 redemption rates averaged 94.7% — meaning that for every $100 of SPAC trust capital, roughly $94.70 was redeemed rather than held through to deal close. Q2 2025 saw that figure rise slightly to 97.6%, which represented the statistical noise of a small number of particularly high-redemption transactions pulling the average up. The directional turn came in Q3 2025, when rates fell to 78.8%, and continued in Q4 2025, when the average dropped to 68.3%.

The Q4 2025 figure of 68.3% is still high in absolute terms. In a traditional IPO, redemption is not a concept — investors who participate in the IPO do so by choice, and the capital raised is committed. A SPAC with 68% redemption has lost two-thirds of its public trust capital and must cover that gap through PIPE financing or alternative sources. But the directional improvement from 94.7% in Q1 to 68.3% in Q4 suggests that deal quality, target selection, and investor engagement improved meaningfully as the year progressed. The cohort of Q4 2025 transactions, which set the direction for 2026, is structurally stronger than the Q1 cohort.

The redemption rate trend also reflects the broader PIPE market recovery. The return of $10.00 PIPE pricing — where institutional investors pay full price for shares in a company whose deal has not yet closed — was specifically identified by Gallagher and Ellenoff's market review as the leading indicator of SPAC market health restoration. When PIPEs price at $10.00, it means sophisticated capital is entering the transaction at the original SPAC IPO price, without requiring a discount for deal or execution risk. This confidence flows directly into lower redemption rates, because institutional PIPE participation signals to public SPAC shareholders that credible investors believe in the transaction.

The Active Pipeline — $55.6 Billion in Trust

As of early 2026, approximately 245 SPACs were actively searching for business combination targets, holding a combined approximately $55.6 billion in trust accounts. This represents a substantial pool of committed, immediately available capital for companies that qualify as acquisition targets — a very different supply-side dynamic than existed during the 2023 trough, when only a handful of credible searching vehicles remained active.

The $55.6 billion figure requires context. Not all of this capital will survive to deal close. Extension votes, shareholder redemptions, and trust account erosion through management fee and working capital withdrawals will reduce the effective capital available in each vehicle. The median deal capital actually deployed after redemptions in a typical 2025 SPAC transaction was substantially lower than the face value of the trust account. Companies evaluating SPAC targets should model multiple redemption scenarios — including 70%, 85%, and 95% redemption — to determine whether the remaining trust capital, combined with a realistically available PIPE, provides sufficient funding for their transaction.

The diversity of the searching cohort is also relevant. The 245 active SPACs include vehicles of varying sizes, sector focuses, and trust deadlines. Companies in technology, healthcare, fintech, defense technology, and energy transition have the most active sponsor interest in 2026. Companies in sectors with limited public market comparables or with complex international operations face a smaller set of sponsors with appropriate expertise and PIPE investor relationships. Matching a company's profile to the right subset of active SPACs is a critical first step in any de-SPAC evaluation process.

Deal Quality in the Recovery Cohort — What the Numbers Cannot Yet Show

Any assessment of the 2025 SPAC recovery must be honest about what the available data cannot yet tell us. SPAC performance is measured over holding periods that extend one to three years beyond the deal close date. The 2025 transactions that closed in the second half of the year will not produce reliable one-year post-close performance data until late 2026 and into 2027. The historical record — University of Florida research covering 2012 through 2024 showing that de-SPAC total returns were below market every single year — reflects a universe that includes the structurally distorted 2020–2021 cohort. Whether the 2025 and 2026 cohort will perform differently is an open empirical question.

There are structural reasons to expect the current cohort to outperform its predecessors. Tighter regulatory standards eliminate some of the most egregious valuation and disclosure practices. Serial sponsor discipline and better target selection reduce the volume of transactions that should never have been done. Smaller trust sizes mean deals require less capital to be viable, and target companies are priced more realistically. The survival of the redemption and PIPE market means that transactions that cannot attract institutional support are less likely to reach close.

None of these structural improvements guarantee superior performance. The fundamental economics of SPAC dilution — 20% founder shares at nominal cost, rights or warrant conversion shares, PIPE discounts, and deferred underwriting fees — still create headwinds that the combined company must overcome through exceptional organic growth. The improvement in 2025 structural quality raises the probability of better outcomes relative to the 2020–2021 cohort; it does not guarantee them. Companies evaluating the de-SPAC path should model these dilution dynamics with specificity before committing to the structure.

Outlook for the Remainder of 2026

The outlook for the SPAC market through the remainder of 2026 is constructive but not euphoric. The volume recovery from 2023's trough appears durable, supported by the structural improvements described above and by a broader IPO market environment that is generally supportive of new listings. AI, healthcare, and fintech sectors continue to generate strong sponsor and PIPE investor interest. Cross-border SPAC activity — particularly involving targets from Asia-Pacific and Latin America seeking U.S. listings — has increased and is expected to continue.

The risks to this outlook are primarily external. Market volatility driven by macroeconomic uncertainty, interest rate movements, or geopolitical events can rapidly suppress PIPE investor appetite and trigger the high redemption rates that make transactions unworkable. The 2022 experience — when rising interest rates and market volatility ended the SPAC boom abruptly — demonstrated how quickly external conditions can override structural improvements. The current market is more resilient than 2021–2022 because it is more selective, but it is not immune to macro headwinds.

For target companies, the 2026 SPAC market offers a genuine, well-resourced, and structurally improved acquisition universe. The approximately 245 searching SPACs holding $55.6 billion represent real capital with real sponsors motivated to execute disciplined transactions. The challenge is matching the right company to the right vehicle — a process that benefits from systematic market intelligence, accurate redemption modeling, and an honest assessment of how the company's financial profile, governance readiness, and sector positioning align with the available sponsor universe. Companies that approach that match-making process rigorously are more likely to reach a successful close than those that accept the first inbound SPAC term sheet without comparative analysis.